Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.

@article{Turpie2011RivaroxabanFT,
  title={Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.},
  author={Alexander G. G. Turpie and Michael Rud Lassen and Bengt Eriksson and Michael J. Gent and Scott D. Berkowitz and Frank Misselwitz and Tiemo J Bandel and Martin Homering and T. Westermeier and Ajay Kakkar},
  journal={Thrombosis and haemostasis},
  year={2011},
  volume={105 3},
  pages={444-53}
}
Four phase III studies compared oral rivaroxaban with subcutaneous enoxaparin for the prevention of venous thromboembolism (VTE) after total hip or knee arthroplasty (THA or TKA). A pooled analysis of these studies compared the effect of rivaroxaban with enoxaparin on symptomatic VTE plus all-cause mortality and bleeding events, and determined whether these effects were consistent in patient subgroups. Patients (N=12,729) aged ≥18 years and scheduled for elective THA or TKA received rivaroxaban… CONTINUE READING
102 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 102 extracted citations

Similar Papers

Loading similar papers…